脊髓灰质炎病毒疫苗制备与使用中的注意事项。 - Suppr

Suppr

超能文献

Considerations in the preparation and use of poliomyelitis virus vaccine.

作者信息

SALK J E

出版信息

J Am Med Assoc. 1955 Aug 6;158(14):1239-48. doi: 10.1001/jama.1955.02960140001001.

DOI:10.1001/jama.1955.02960140001001

PMID:14392073

Abstract

摘要

相似文献

Considerations in the preparation and use of poliomyelitis virus vaccine.

J Am Med Assoc. 1955 Aug 6;158(14):1239-48. doi: 10.1001/jama.1955.02960140001001.

Statistical methods: poliomyelitis vaccine evaluation.

Med Bull (Ann Arbor). 1955 Jun;21(6):209-12.

1954 Poliomyelitis vaccine field trial; plan, field operations, and follow-up observations.

J Am Med Assoc. 1955 Aug 6;158(14):1258-65. doi: 10.1001/jama.1955.02960140020003.

SOME REFLECTIONS on the Salk vaccine.

J Pediatr. 1955 Jul;47(1):137-40. doi: 10.1016/s0022-3476(55)80139-4.

State polio vaccine programs.

J Natl Med Assoc. 1955 May;47(3):184-7.

THE OUTLOOK for poliomyelitis vaccination.

Lancet. 1955 Jun 11;268(6876):1207-8.

Vaccination against poliomyelitis in Copenhagen.

Manedsskr Prakt Laegegern. 1955 Apr;33(4):182-4.

Present status of the problem of vaccination against poliomyelitis.

Am J Public Health Nations Health. 1955 Mar;45(3):285-97. doi: 10.2105/ajph.45.3.285.

[Suggestion on the immunization period of Salk vaccine].

Dia Med. 1955 Jun 23;27(42):1283.

Public health implications in a program of vaccination against poliomyelitis.

J Am Med Assoc. 1955 Aug 6;158(14):1249-58. doi: 10.1001/jama.1955.02960140011002.

引用本文的文献

Molecular ingredients of an immunogen for long-lasting IgG.

Front Immunol. 2025 Aug 19;16:1639371. doi: 10.3389/fimmu.2025.1639371. eCollection 2025.

Two centuries of vaccination: historical and conceptual approach and future perspectives.

Front Public Health. 2024 Jan 9;11:1326154. doi: 10.3389/fpubh.2023.1326154. eCollection 2023.

Strategies for Vaccine Prioritization and Mass Dispensing.

Vaccines (Basel). 2021 May 14;9(5):506. doi: 10.3390/vaccines9050506.

Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy.

Viruses. 2021 Apr 21;13(5):720. doi: 10.3390/v13050720.

Interferons and other cytokines, genetics and beyond in COVID-19 and autoimmunity.

Cytokine Growth Factor Rev. 2021 Apr;58:134-140. doi: 10.1016/j.cytogfr.2021.01.004. Epub 2021 Jan 29.

Enteric Viral Co-Infections: Pathogenesis and Perspective.

Viruses. 2020 Aug 18;12(8):904. doi: 10.3390/v12080904.

Were there long-term economic effects of exposure to polio vaccination? An analysis of migrants to Sweden 1946-2003.

SSM Popul Health. 2020 May 20;11:100589. doi: 10.1016/j.ssmph.2020.100589. eCollection 2020 Aug.

Multiplex PCR-Based Neutralization (MPBN) Assay for Titers Determination of the Three Types of Anti-Poliovirus Neutralizing-Antibodies.

Vaccines (Basel). 2020 Mar 5;8(1):120. doi: 10.3390/vaccines8010120.

Development of Thermostable Lyophilized Sabin Inactivated Poliovirus Vaccine.

mBio. 2018 Nov 27;9(6):e02287-18. doi: 10.1128/mBio.02287-18.

High variability of genomic instability and gene expression profiling in different HeLa clones.

Sci Rep. 2015 Oct 20;5:15377. doi: 10.1038/srep15377.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Considerations in the preparation and use of poliomyelitis virus vaccine.

J Am Med Assoc. 1955 Aug 6;158(14):1239-48. doi: 10.1001/jama.1955.02960140001001.

Statistical methods: poliomyelitis vaccine evaluation.

Med Bull (Ann Arbor). 1955 Jun;21(6):209-12.

1954 Poliomyelitis vaccine field trial; plan, field operations, and follow-up observations.

J Am Med Assoc. 1955 Aug 6;158(14):1258-65. doi: 10.1001/jama.1955.02960140020003.

SOME REFLECTIONS on the Salk vaccine.

J Pediatr. 1955 Jul;47(1):137-40. doi: 10.1016/s0022-3476(55)80139-4.

State polio vaccine programs.

J Natl Med Assoc. 1955 May;47(3):184-7.

THE OUTLOOK for poliomyelitis vaccination.

Lancet. 1955 Jun 11;268(6876):1207-8.

Vaccination against poliomyelitis in Copenhagen.

Manedsskr Prakt Laegegern. 1955 Apr;33(4):182-4.

Present status of the problem of vaccination against poliomyelitis.

Am J Public Health Nations Health. 1955 Mar;45(3):285-97. doi: 10.2105/ajph.45.3.285.

[Suggestion on the immunization period of Salk vaccine].

Dia Med. 1955 Jun 23;27(42):1283.

Public health implications in a program of vaccination against poliomyelitis.

J Am Med Assoc. 1955 Aug 6;158(14):1249-58. doi: 10.1001/jama.1955.02960140011002.

引用本文的文献

Molecular ingredients of an immunogen for long-lasting IgG.

Front Immunol. 2025 Aug 19;16:1639371. doi: 10.3389/fimmu.2025.1639371. eCollection 2025.

Two centuries of vaccination: historical and conceptual approach and future perspectives.

Front Public Health. 2024 Jan 9;11:1326154. doi: 10.3389/fpubh.2023.1326154. eCollection 2023.

Strategies for Vaccine Prioritization and Mass Dispensing.

Vaccines (Basel). 2021 May 14;9(5):506. doi: 10.3390/vaccines9050506.

Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy.

Viruses. 2021 Apr 21;13(5):720. doi: 10.3390/v13050720.

Interferons and other cytokines, genetics and beyond in COVID-19 and autoimmunity.

Cytokine Growth Factor Rev. 2021 Apr;58:134-140. doi: 10.1016/j.cytogfr.2021.01.004. Epub 2021 Jan 29.

Enteric Viral Co-Infections: Pathogenesis and Perspective.

Viruses. 2020 Aug 18;12(8):904. doi: 10.3390/v12080904.

Were there long-term economic effects of exposure to polio vaccination? An analysis of migrants to Sweden 1946-2003.

SSM Popul Health. 2020 May 20;11:100589. doi: 10.1016/j.ssmph.2020.100589. eCollection 2020 Aug.

Multiplex PCR-Based Neutralization (MPBN) Assay for Titers Determination of the Three Types of Anti-Poliovirus Neutralizing-Antibodies.

Vaccines (Basel). 2020 Mar 5;8(1):120. doi: 10.3390/vaccines8010120.

Development of Thermostable Lyophilized Sabin Inactivated Poliovirus Vaccine.

mBio. 2018 Nov 27;9(6):e02287-18. doi: 10.1128/mBio.02287-18.

High variability of genomic instability and gene expression profiling in different HeLa clones.

Sci Rep. 2015 Oct 20;5:15377. doi: 10.1038/srep15377.